جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

140 مُخرَج نتائج البحث عن «Frontier»

مقالوصول مفتوح20263استشهاد· Semantic Scholar

Prevalence of hyperemesis gravidarum and its associated electrolyte and hematologic disturbances in pregnant women

Frontiers in Medicine · مجلد 13 · 1703120-1703120

Background and objective: Hyperemesis gravidarum (HG) is a condition that develops early in pregnancy, before 16 weeks of gestation, and is characterized by severe nausea and/or vomiting, inability to tolerate food and/or beverages, and substantial impairment of daily activities. Hyperemesis gravidarum can have obvious maternal and fetal consequences. This study aimed to assess the prevalence of HG, investigate its associated electrolyte and hematologic disturbances, and identify risk factors among pregnant women in Aljouf, Saudi Arabia. Methods: A retrospective observational case-control study was conducted using 200 medical records selected from a total of 9,090 records of pregnant women at the Maternity and Children Hospital in Aljouf, covering the period from November 2020 to November 2023. Results: The prevalence of hyperemesis gravidarum was 1.1% among the studied pregnant women. Patients diagnosed with hyperemesis gravidarum showed significantly lower body weight and BMI than controls. Nearly 48% of HG cases occurred in women aged 30-39 years, while 52% were in the first trimester. Furthermore, 36% of the affected women were primigravida, and 11% were pregnant with twins. Hypotension was observed in 35% of HG cases. Hyponatremia occurred in 29% of patients, hypokalemia in 21%, and hypochloremia in 24%. Hematological disturbances included increased Hb levels in 11% of cases, increased hematocrit in 12%, leukocytosis in 19%, and neutrophilia in 17% of the patients. Conclusion: Hypotension, electrolyte imbalance, and hematological disturbances are the primary consequences of HG. First-trimester pregnancy and low gestational age are the most important risk factors for HG. Strategies by healthcare centers and further research are needed to enhance the treatment, management, and prevention methods of HG.

hyperemesis gravidarumprevalenceelectrolyte imbalancehyponatremia
مقالوصول مفتوح20263استشهاد· Semantic Scholar

Barriers and enablers affecting female participation in physical activity

Frontiers in Global Women s Health · مجلد 6 · 1707792-1707792

Background: Physical activity offers numerous health benefits and helps prevent various diseases, making it an essential component of a healthy lifestyle. Objective: This study aims to examine the barriers and enablers that affect female participation in physical activity. Methods: This was a cross-sectional quantitative study. The study questionnaire was adopted from a previous study. The survey was conducted online and completed by 668 Saudi women from across the country. Results: The study findings regarding low physical activity levels among Saudi women are concerning, as 72.2% of participants were classified as sedentary or physically inactive. The study revealed that age, employment status, and income were significant factors affecting engagement of women in physical activity. Moreover, barriers such as expensive gym memberships, a lack of women-only clubs, a lack of enjoyment in sports, and prolonged use of the same exercise devices prevented Saudi women from participating in physical activities. However, women reported exercising to boost their self-satisfaction and self-confidence, thereby promoting overall health. Conclusion: Saudi women exhibit a low level of physical activity. Barriers such as expensive gym memberships, a lack of women-only clubs, a lack of enjoyment in sports, prolonged use of the same exercise devices, and motivations related to self-satisfaction and self-confidence prevent Saudi women from practicing physical activities. Health system policymakers need to take action to increase physical activity levels and address these barriers.

physical activitybarriers to exercisesedentary behaviorSaudi women
مقالوصول مفتوح20262استشهاد· Semantic Scholar

High-intensity versus low-intensity laser acupuncture in chronic, non-specific low back pain: a double-blinded, randomized controlled trial

Frontiers in Medicine · مجلد 13 · 1857622-1857622

Background: Chronic nonspecific low back pain (CNSLBP) is a musculoskeletal condition characterized by persistent discomfort, weak trunk muscles, exhaustion, and disability. Objectives: The purpose of this study is to compare the effects of high-intensity laser acupuncture (HILA) and low-intensity laser acupuncture (LILA), combined with exercise, on strength of trunk extensors, fatigue, level of pain, range of motion (ROM) of lumbar flexion, and disability in patients with CNSLBP. Materials and methods: 60 participants with CNSLBP were divided into three groups in this randomized, double-blind, sham-controlled trial: the high-intensity laser (HILA) group, who received HILA over 15 acupuncture points along with exercises; the low-intensity laser (LILA) group, who received LILA over the same points plus exercises; and the sham group, who received sham laser in addition to exercises. The interventions were received three times/week for four consecutive weeks. The strength of trunk extensors, fatigue, pain, lumbar flexion ROM, and disability were measured at baseline, after 4 weeks, and at a 1-month follow-up. The assessment tools used included isokinetic dynamometry, the visual analogue scale (VAS), the modified Schober test (MST), and the Oswestry Disability Index (ODI). Results: < 0.05). However, fatigue and disability did not differ between the two active laser groups. All groups showed minor changes between the post-treatment and follow-up periods. Conclusion: Patients with CNSLBP may have a short-term benefit from HILA and LILA combined with exercise rather than from exercise alone in terms of trunk extensor strength and fatigue, pain, lumbar flexion ROM, and disability. However, both laser treatments showed comparable effects on fatigue and disability; HILA appears to be more effective than LILA in improving trunk extensor strength and relieving pain. To define the ideal treatment parameters and to evaluate long-term effects, further research is required. Clinical Trial Registration: https://clinicaltrials.gov/, identifier [NCT06280846].

chronic non-specific low back painlaser acupunctureexercise therapytrunk extensor strength
مقالوصول مفتوح20262استشهاد· Semantic Scholar

Novel anti-virulence strategy against Helicobacter pylori using Lactiplantibacillus plantarum cell-free supernatants

Frontiers in Microbiology · مجلد 17 · 1881796-1881796

Helicobacter pylori is one of the most prevalent pathogenic microorganisms worldwide. The treatment of H. pylori infections is challenging due to the increasing antibiotic resistance. Therefore, alternative therapies are crucial for addressing these issues. This study aimed to investigate alternative approaches to combat H. pylori infection using lactic acid bacteria. Nineteen LAB isolates exhibited strong tolerance to simulated gastric acid and bile salts, as well as notable auto-aggregation and co-aggregation capabilities. Among them, isolates L20, L22, and L40 showed superior performance. Their neutralized cell-free supernatants (n-CFSs) significantly inhibited H. pylori urease production by 69, 66, and 67%, respectively, and reduced biofilm formation by 88, 82, and 80%, respectively. Molecular identification revealed that isolates L20 and L40 belonged to Lactiplantibacillus plantarum , while L22 was identified as Limosilactobacillus fermentum . Furthermore, the n-CFS of L. plantarum L20 markedly downregulated the expression of H. pylori virulence genes, including vacA , cagA , ureA , and babA, with fold reductions of 79, 68, 90, and 96%, respectively. In vivo , treatment with L. plantarum L20 n-CFS resulted in 1.28 log reduction in H. pylori colonization ( p < 0.001). Proteomic analysis further identified metabolically active proteins associated with catalytic and secondary metabolite pathways, supporting their mechanistic role in anti- H. pylori activity. These findings highlight the potential of LAB-derived n-CFS, particularly L. plantarum L20, as a promising antivirulent strategy against H. pylori infections.

Helicobacter pylorianti-virulence strategiesLactobacillus plantarumcell-free supernatant
مقالوصول مغلق20262استشهاد· Semantic Scholar

DFT and Molecular Dynamics Guided Pharmacokinetic Evaluation of Phenyl Styryl Ketone Derivatives as Potential MAO‐B Inhibitors

ChemistrySelect · مجلد 11 (2)

ABSTRACT This research explores the capacity of phenyl styryl ketone derivatives to inhibit monoamine oxidase B (MAO‐B), a key enzyme associated with neurodegenerative disorders. From frontier molecular orbital (FMO) studies, reactivity parameters of the drug candidates were found out. Ligands were submitted to absorption, digestion, metabolism, excretion, and toxicity (ADMET) analysis to ensure their potential drugability and safety. To understand the electronic description of ligand interaction, natural bond orbital (NBO) analysis was conducted, and the presence of heteroatoms was proven crucial. The reduced density gradient (RDG) studies, together with molecular electrostatic surface potential (MESP) analysis, were able to provide the ligand's active sites and nature of interaction. Docking studies were conducted to study the interaction between the protein (P) and ligand (L) at the MAO‐B catalytic region, alongside a comparison with safinamide, a recognized MAO‐B inhibitor. Molecular dynamics (MD) simulations were utilized to examine the protein–ligand complex (PLC). The molecular mechanics Poisson–Boltzmann surface area (MM‐PBSA) method was applied to predict the binding affinity and interaction. We also analyzed structural stability, solvation, and decomposition. Of the four ligands examined, CHA_1.4 is found to be the most efficient. The contact map method was useful in identifying the key amino acids; in all the complexations we have considered, TYR398 has interacted most with the drug candidates. The finding was in agreement with the decomposition profile of the PLC. For the principal component analysis (PCA), topology formats and 100 ns MD trajectories are used to learn more about how proteins fold. Replicates were also done to validate the reported study and are represented as box‐whisker plots. The study's findings provide valuable insights for the development of new MAO‐B inhibitors.

monoamine oxidase B inhibitorsmonoamine oxidase Bneurodegenerative diseasesfrontier molecular orbitals
مقالوصول مفتوح20261استشهاد· Semantic Scholar

GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon

Frontiers in Aging Neuroscience · مجلد 18

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed as antidiabetic agents, have emerged as candidate disease-modifying therapies for Parkinson’s disease (PD) and Alzheimer’s disease (AD), reflecting the widespread expression of GLP-1 receptors across neurons, glia, and the cerebral vasculature. This narrative review synthesizes mechanistic, clinical trial, and biomarker evidence for GLP-1 RAs in PD and AD, based on a literature search of PubMed, Embase, Scopus, and Web of Science, with ClinicalTrials.gov searched separately for trial protocols and results, through May 2026. Preclinical data implicate GLP-1 receptor agonism in anti-neuroinflammatory signaling, mitochondrial preservation, autophagy and proteostasis enhancement, anti-apoptotic effects, synaptic plasticity, cerebrovascular protection, and glymphatic clearance. Clinical evidence in PD is mixed and agent- and formulation-dependent: the phase II Exenatide-PD trial reported a motor benefit that persisted after washout (∼3.5-point between-group difference in MDS-UPDRS Part III), and the phase II LIXIPARK trial (lixisenatide) reported a significant 3.08-point between-group difference (95% CI 0.86–5.30; p = 0.007) favoring lixisenatide, whereas the larger, longer phase III Exenatide-PD3 trial, using an extended-release weekly formulation, found no significant effect on the same endpoint (adjusted coefficient 0.92; 95% CI −1.56 to 3.39; p = 0.47); oral semaglutide is under investigation in the ongoing phase II MOST-ABLE trial. In AD, the phase IIb liraglutide (ELAD) trial did not achieve statistical benefit on either its primary imaging endpoint (cerebral glucose metabolic rate; p = 0.14) or on most secondary cognitive measures, and the phase III semaglutide trials EVOKE and EVOKE+ did not meet their primary CDR-SB endpoint (estimated difference −0.08, 95% CI −0.35 to 0.20, p = 0.57 in EVOKE; 0.10, 95% CI −0.17 to 0.38, p = 0.46 in EVOKE+), despite biomarker signals including reductions in cerebrospinal fluid tau species and inflammatory markers. Comparative pharmacology reveals substantial heterogeneity in central nervous system penetration, receptor engagement, and systemic bioavailability across exenatide, liraglutide, semaglutide, and the imbalanced GLP-1/GIP co-agonist tirzepatide, complicating cross-agent extrapolation. Persistent challenges include separating direct neuroprotection from indirect metabolic and cardiovascular benefit, limited characterization of brain drug exposure, trial durations that may be short relative to the expected latency of a disease-modifying effect, and the absence of validated response biomarkers. We conclude that although the mechanistic and epidemiological rationale for GLP-1 RAs in neurodegeneration remains biologically plausible, current trial evidence does not yet support their use outside clinical trials, irrespective of comorbid diabetes status; future studies should prioritize earlier intervention, biomarker-guided patient selection, adequately powered subgroup analyses, and brain-penetrant formulations.

GLP-1 receptor agonistsParkinson's diseaseAlzheimer's diseasedisease-modifying therapy
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Buspirone attenuates cyclophosphamide-induced renal dysfunction in association with alterations in miR-205/EGLN2, Nrf2, and PERK/ATF4/CHOP signaling

Frontiers in Pharmacology · مجلد 17 · 1871321-1871321

Background Although microRNAs have been investigated, the reno-protective role of microRNA-205 (miR-205) in cyclophosphamide (CPA)-induced nephrotoxicity has not yet been explored. Therefore, this study evaluated the influence of buspirone on miR-205 and its downstream target EGLN2, focusing on oxidative and ER stress as key drivers of renal injury. This represents a significant gap in nephrotoxicology and epigenetic Toxicology research. Methods Animals were randomly allocated among four groups (n = 8), including the normal control group and the CPA group that received one intraperitoneal injection of CPA at 200 mg/kg on day 7. Buspirone at 5 or 10 mg/kg per day was administered by oral gavage for ten consecutive days, whereas CPA injected on the seventh day. At experimental completion, blood samples and renal tissues were subjected to analysis using biochemical, histopathological, immunohistochemical, Western blotting, and qRT-PCR techniques. Results CPA induced marked renal dysfunction, reflected by elevated SCr, BUN, NGAL, and KIM-1, with evident histopathological damage. This was accompanied by miR-205 suppression, EGLN2 upregulation, impaired Nrf2 signaling, increased PC levels, and stimulation of PERK/eIF2α/ATF4/CHOP-linked ER stress signaling ( p < 0.01). Concurrently, activation of JNK1, Fos, and NF-κB increased inflammatory cytokines, and initiated caspase-dependent apoptotic signaling ( p < 0.01). Buspirone pretreatment mitigated these alterations, accompanied by increased miR-205 expression, reduced EGLN2 expression, enhanced Nrf2-associated antioxidant defenses, and attenuation of ER stress, inflammation, and apoptosis, thereby preserving renal function and tissue integrity. Conclusion These findings highlight the preventive renoprotective potential of buspirone against CPA-induced nephrotoxicity and underscore the relevance of miR-205/EGLN2 signaling in renal stress responses. Future toxicokinetic and toxicodynamic studies should evaluate buspirone’s safety in tumor treatment.

buspironemicroRNA-205EGLN2Nrf2 signaling
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Knowledge, attitudes, and practices toward obesity and their determinants: a cross-sectional study

Frontiers in Public Health · مجلد 14 · 1768449-1768449

Background: Obesity remains a major global health challenge and a significant contributor to chronic diseases. This study aimed to assess knowledge, attitudes, and practices (KAP) related to obesity and to identify sociodemographic and clinical factors influencing these domains among individuals with obesity. Methods: A cross-sectional survey was conducted using a convenience, non-probability sampling method among individuals with obesity recruited from hospitals, health clinics, and community settings. Obesity-related knowledge, attitudes, and practices were assessed, and multinomial regression analyses were performed to identify factors associated with KAP outcomes. Results: A total of 419 participants were included, with a nearly equal gender distribution and a predominantly young adult population, most of whom had university-level education. Overall, 45.3% demonstrated satisfactory knowledge, 42.2% exhibited positive attitudes, and 43.0% reported effective practices regarding obesity management. Increasing age (OR = 1.361, 95% CI: 1.134-1.635) and higher education (OR = 2.417, 95% CI: 1.575-3.710) were significantly associated with satisfactory knowledge. Male participants were more likely to exhibit negative attitudes than females (OR = 1.909, 95% CI: 1.141-3.195), while individuals diagnosed with obesity were less likely to report non-satisfactory attitudes (OR = 0.495, 95% CI: 0.290-0.845). Effective practices were associated with age (OR = 1.296, 95% CI: 1.076-1.562) and obesity diagnosis (OR = 0.475, 95% CI: 0.278-0.811). Perceptions of nutritional value significantly influenced both knowledge (OR = 0.741, 95% CI: 0.571-0.961) and practices (OR = 0.384, 95% CI: 0.288-0.512). Conclusion: The findings highlight the role of key sociodemographic and clinical factors-particularly age, education, and obesity diagnosis-in shaping obesity-related knowledge, attitudes, and practices. Targeted educational and behavioral interventions, especially among younger individuals and males, along with improved awareness of nutritional value, may enhance obesity management outcomes.

obesityknowledge, attitudes and practicesobesity treatmentsociodemographic factors
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Knowledge, attitudes, practices, and barriers toward drug–drug interaction management among pharmacists in Riyadh, Saudi Arabia: a cross-sectional study

Frontiers in Public Health · مجلد 14 · 1727731-1727731

Background Drug–drug interactions (DDIs) pose a serious challenge in pharmaceutical care, affecting medication safety and treatment outcomes. Pharmacists play a crucial role in identifying, preventing, and managing DDIs. This study aimed to evaluate the knowledge, attitudes, practices, and perceived barriers related to DDIs among pharmacists in Riyadh, Saudi Arabia, between September and December 2024. Methods A cross-sectional survey was conducted among pharmacists in Riyadh using a structured questionnaire to gather demographic data and assess knowledge, attitudes, practices, and perceived barriers toward DDI management. Statistical analyses, including correlation and binary logistic regression, were employed to investigate the associations. Results Among the participants, 63.8% were 30–39 years (40.8%). A moderate positive correlation was found between attitudes and practices ( r = 0.439, P < 0.001), suggesting that favorable attitudes were associated with better practices. Female pharmacists ( P < 0.001, OR = 0.381) and those with formal DDI training ( P < 0.001, OR = 5.467) reported significantly better practices. Perceived barriers were lower among younger pharmacists ( P = 0.024, OR = 0.593), those with higher qualifications ( P = 0.004, OR = 0.675), and those in specific work settings ( P < 0.001, OR = 0.621), while more experienced pharmacists reported greater barriers ( P < 0.001, OR = 1.933). Formal training did not significantly impact perceived barriers ( P = 0.201). Conclusion Formal training in DDIs markedly improves pharmacists' practices. Younger age and higher qualifications are associated with fewer perceived barriers. Tailored educational interventions are crucial to enhance DDI management and promote patient safety.

drug-drug interactionspharmacist knowledge, attitudes and practicesperceived barrierspharmaceutical care
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Diabetic retinopathy severity detection using an improved Whale optimization algorithm and convolutional Kolmogorov-Arnold network

Frontiers in Medicine · مجلد 13 · 1709872-1709872

Introduction: Diabetic retinopathy (DR) is an inflammatory condition affecting the retina caused by elevated and unregulated blood glucose levels. On a global scale, it is a contributing factor to vision impairment. Several deep learning (DL) methods use retinal images to identify DR severity. However, a significant improvement is required to assist medical professionals in recognizing DR in its early phases. Methods: Thus, the author introduced a method based on the DL technique to determine the DR severity grades using retinal images. A ShuffleNet V2 model with vision transformers' (ViT) attention mechanism was used to extract the features. An improved Whale optimization method (IWO) was used to fine-tune the feature extraction model. We employed a convolutional Kolmogorov-Arnold Network to categorize the DR severity using the extracted features. The EyePACS dataset was utilized to train the proposed DR severity grading model using a five-fold cross-validation strategy. We generalized the model on the Messidor-2 dataset. Results: The findings revealed an average accuracy of 93.84% on the MESSIDOR-2 dataset, demonstrating a substantial improvement in detecting DR using the fundus images. Discussion: Furthermore, the model demands minimal processing resources to generate the outcomes, leading to the deployment of the proposed DR severity detection model in healthcare facilities with limited computational resources.

diabetic retinopathyseverity classificationfundus imageswhale optimization algorithm
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Oxytocin restores cognitive function and attenuates neuroinflammation in chronic sleep-deprived aged rats

Frontiers in Aging Neuroscience · مجلد 18 · 1742343-1742343

Background: Sleep is a fundamental biological process essential for maintaining mental, emotional, and physical health. Chronic sleep deprivation (SD), particularly in aging, is associated with oxidative stress, neuroinflammation, apoptosis, and cognitive and behavioral impairments. Oxytocin, a hypothalamic neuropeptide with reported antioxidant and anti-inflammatory properties, may modulate stress-related pathways; however, its role in mitigating SD-induced brain alterations remains unclear. This study investigated whether peripheral oxytocin administration influences brain and behavioral changes induced by chronic SD in aged rats. Methods: Male Sprague Dawley rats aged 20-24 months were divided into four groups: control, oxytocin-treated, SD, and SD with oxytocin treatment. Chronic SD was induced using a modified multiple platform method. Behavioral assessments were conducted to evaluate locomotor and exploratory activity. Serum cortisol was measured as a systemic stress marker, while brain tissues were analyzed for oxidative stress and inflammatory markers. Gene expression of Psen1 and Htr2a, oxytocin receptor protein levels, and histopathological changes, including gliosis and apoptosis, were also evaluated. Results: Chronic SD resulted in significant impairments in locomotor and exploratory behaviors, elevated serum cortisol levels, and increased oxidative stress and inflammatory markers. SD also altered the expression of Psen1 and Htr2a, reduced oxytocin receptor protein levels, and was associated with histological evidence of gliosis and apoptosis in brain tissues. Peripheral oxytocin administration attenuated many of these SD-induced alterations. However, because oxytocin was administered peripherally and central oxytocin levels or receptor engagement were not directly assessed, the findings cannot be interpreted as definitive evidence of direct central neuroprotection. Conclusion: The results suggest that oxytocin modulates stress responses, oxidative balance, and inflammatory pathways in aged rats subjected to chronic sleep deprivation. Although the precise central mechanisms remain unresolved, these findings support a potential role for oxytocin in mitigating SD-associated pathophysiological changes in aging and warrant further mechanistic studies to clarify its neuroprotective potential.

oxytocinchronic sleep deprivationagingneuroinflammation
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Efficacy of combined Kinesio-taping with chest physiotherapy program on pain, pulmonary function, respiratory muscle strength and quality of life after mastectomy: a randomized controlled trial

Frontiers in Medicine · مجلد 12 · 1664210-1664210

Objectives This study aimed to assess the effects of incorporating Kinesio-taping (KT) into a chest physical therapy program on alleviating pain and enhancing pulmonary function, respiratory muscle strength, and quality of life following mastectomy. Design This was a prospective, randomized controlled trial. Setting Physiotherapy outpatient clinic. Participants Sixty participants aged 30–50 years who had undergone modified radical mastectomy were randomly allocated to either the Kinesio-taping or traditional physical therapy exercise group. Intervention The Kinesio-taping group received both Kinesio-taping and traditional chest physiotherapy. The control group received only the traditional chest physiotherapy program. The interventions were administered over a 4-week period. Outcome measures The primary outcome measure was pain, which was evaluated using a visual analogue scale (VAS). Secondary outcomes included pulmonary function, specifically forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), assessed via spirometry; respiratory muscle strength, determined by measuring maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) using a portable pressure device; and quality of life, assessed using the Short Form-36 (SF-36) questionnaire. All outcomes were measured at baseline and 4 weeks after the intervention. Results The evaluated parameters exhibited significant alterations between the pre- and post-intervention after a duration of 4 weeks in both groups. The results indicated a significant changes ( p < 0.001) in post-intervention measures compared to pre-intervention measures in both groups. No significant differences were observed between the groups before the intervention. The KT group demonstrated superior postintervention outcomes. Specifically, the KT group showed a significant reduction in VAS scores post-intervention than the control group (3.97 ± 1.65 vs. 6.50 ± 1.57, p < 0.001). Post-intervention, the KT group exhibited significantly higher values ( p < 0.001) of FVC, FEV1, and FEV1/FVC (3.52 ± 0.64 L, 2.95 ± 0.56 L, and 85.09 ± 12.07%) compared to the control group (2.38 ± 0.56 L, 1.74 ± 0.54 L, and 72.39 ± 10.82%), respectively. Additionally, post-intervention MIP and MEP values were significantly higher ( p < 0.001) in the KT group. Conclusion Integrating Kinesio-taping into a standard chest physiotherapy program significantly reduced pain and enhanced pulmonary function, respiratory muscle strength, and quality of life in post-mastectomy patients compared to the application of traditional chest physiotherapy alone. Clinical trial registration ClinicalTrials.gov , identifier NCT06701591.

kinesio tapingchest physiotherapymastectomypostoperative pain
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Pulmonary and extra-pulmonary infections caused by classical and hypervirulent Klebsiella pneumoniae: a prospective cross-sectional study

Frontiers in Microbiology · مجلد 16 · 1707017-1707017

Aim Klebsiella pneumoniae ( K. pneumoniae ) is an opportunistic pathogen causing infections ranging from pulmonary disease to severe systemic illness. This study aimed to examine the relationships between infection site, pathotype, virulence, resistance, and clinical presentations to manage classical (cKp) and hypervirulent (hvKp) strains. Methods and results 600 clinical specimens were screened for K. pneumoniae . Virulence and resistance fitness were analyzed phenotypically and genotypically. Clinical correlations were assessed to link pathotype, resistance, virulence, infection site, age, and presentation. K. pneumoniae was detected in 17.2% specimens (103/600), with pulmonary samples showing 43% positivity versus 12% in extra-pulmonary ones. hvKp accounted for 55.3% and cKp for 44.7% of isolates; hvKp predominated in extra-pulmonary infections (83.3%) and cKp in pulmonary cases (83.7%). K1 (33.1%) and K2 (21.4%) were confined to hvKp, while pulmonary isolates were mainly K3, K5, and K20. Pulmonary infections mainly affected adults (81.4%) and showed respiratory signs; extra-pulmonary cases occurred mostly in pediatric (46.7%) and elderly (41.7%) patients with systemic symptoms such as fever and hypotension. Clustering distinguished pulmonary/cKp (MDR-rich) from extra-pulmonary/hvKp (virulence-rich) isolates, with some overlap indicating hybrid strains. Correlations linked pulmonary infections with cKp and MDR (r = 0.67), and extra-pulmonary infections with hvKp and systemic disease (r = 0.67). Conclusion The high MDR burden of cKp underscores the need for stronger antimicrobial stewardship and new therapies, while the invasive nature of hvKp highlights the importance of early recognition and rapid intervention to prevent systemic complications. Early distinction of cKp from hvKp can significantly influence treatment decisions and reduce morbidity and mortality associated with K. pneumoniae infections.

Klebsiella pneumoniaehypervirulent Klebsiella pneumoniaepulmonary infectionmultidrug resistance
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Integrated design, synthesis, biological evaluation, and computational mechanistic insights of novel benzanilide derivatives as VEGFR-2 targeted anticancer agents

RSC Advances · مجلد 16 (40) · 46282-46300

= 1.79 ± 0.05 µM), supporting its targeted anti-angiogenic mechanism. Flow cytometry analysis showed that 7e induced G0/G1 cell cycle arrest and markedly increased apoptotic cell populations. This was further confirmed by upregulation of Bax, Caspase-3, and Caspase-8, alongside downregulation of Bcl-2, indicating activation of both intrinsic and extrinsic apoptotic pathways. Interestingly, 7e inhibited cancer cell migration, suggesting a potential anti-angiogenetic effect. Density functional theory (DFT) calculations revealed that 7e possesses a conjugated electronic system with a suitable frontier orbital distribution, moderate HOMO-LUMO gap, and a favorable electrostatic potential for receptor interaction. Molecular docking and dynamics simulations demonstrated stable binding of 7e within the VEGFR-2 active site, supported by consistent RMSD, hydrogen bonding, and compact structural behavior. MM-GBSA calculations confirmed favorable binding free energy, while per-residue decomposition and protein-ligand interaction fingerprint analysis identified key stabilizing interactions. Essential dynamics and free energy landscape mapping further confirmed a stable and energetically favorable conformational state. ADMET and toxicity predictions indicated acceptable pharmacokinetic properties, low mutagenic risk, and an overall favorable safety profile. Collectively, these findings identify compound 7e as a promising VEGFR-2-targeted anticancer lead with strong enzymatic inhibition, potent cytotoxicity, and a well-supported mechanistic profile integrating experimental and computational evidence.

VEGFR-2 inhibitorsangiogenesis inhibitorsanticancer agentsapoptosis
مقالوصول مفتوح2026

Tavapadon in Parkinson’s disease: D1/D5 receptor pharmacology, clinical evidence, and translational perspectives

Frontiers in Aging Neuroscience · مجلد 18

Tavapadon is an oral, once-daily, non-catechol partial agonist selective for the D1 and D5 dopamine receptors and represents a mechanistically distinct option currently under clinical investigation for Parkinson disease (PD). This narrative review critically evaluates the biological rationale for D1/D5 receptor targeting, the pharmacological and preclinical development of tavapadon, and the accumulating phase 1–3 clinical evidence for its use as monotherapy in early PD and as adjunctive therapy in patients with motor fluctuations, while highlighting remaining evidence gaps and methodological limitations. A non-systematic literature search of PubMed/MEDLINE, Embase, ClinicalTrials.gov , and Scopus (through May 2026) was performed to identify representative and pivotal randomized controlled trials, pharmacokinetic/pharmacodynamic studies, and mechanistic preclinical investigations relevant to tavapadon and D1/D5 receptor agonism; this narrative approach was not intended to be exhaustive or fully reproducible in the manner of a systematic review. Mechanistically, selective stimulation of the direct striatal pathway together with submaximal intrinsic efficacy at the D1 receptor has been proposed, as a mechanistic hypothesis rather than a demonstrated clinical mechanism, to preserve antiparkinsonian benefit while limiting the receptor-signaling intensity implicated in levodopa-induced dyskinesia. In the phase 2 PARKWAY-II study and the now fully published phase 3 TEMPO-1 and TEMPO-2 trials, fixed- and flexible-dose tavapadon produced clinically meaningful improvements in MDS-UPDRS motor scores compared with placebo in early PD, and in the phase 3 TEMPO-3 trial, adjunctive tavapadon significantly increased daily good ON time and reduced OFF time in levodopa-treated patients with motor fluctuations; efficacy in all trials has been demonstrated only against placebo, with no head-to-head data against levodopa or other dopamine agonists. Adverse events were more frequent with tavapadon than placebo (approximately 72–76% versus 55% across TEMPO-2 and TEMPO-3), with nausea, headache, and dizziness the most common; no excess signal of impulse-control disorders relative to placebo was detected over the available 26–27-week controlled treatment period, and no clinically significant QTc prolongation was observed. The 58-week open-label TEMPO-4 extension, now reported in a peer-reviewed AAN abstract publication in Neurology alongside earlier interim conference data, suggests sustained benefit and a stable long-term levodopa requirement, but lacks a randomized control and cannot yet establish long-term safety superiority over existing agents. Tavapadon is a mechanistically novel candidate with preliminary evidence of efficacy; its ultimate clinical utility will depend on head-to-head trials and long-term safety data.

Parkinson's diseasedopamine D1 receptordopamine D5 receptormotor fluctuations